To be specific, as a protective mechanism in MG patients, when the levels of pro-inflammatory pathway markers represented by AchR-Ab and IL-10 increased, the response of Treg cells including Foxp3+ Treg and Tr1 cells were correspondingly elevated, presenting with the increase level of secreted cytokines. The gene discussed is IL10; the disease is myasthenia gravis.